Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Two-period, Double-crossover Phase 1 Study to Evaluate the Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets in Healthy Subjects
Conditions
Interventions
LPM3770164 sustained release tablet
Locations
1
China
Shanghai Mental Health Center
Shanghai, China
Start Date
July 31, 2024
Primary Completion Date
September 25, 2024
Completion Date
September 25, 2024
Last Updated
December 12, 2024
NCT06826612
NCT07451613
NCT07253038
NCT04012411
NCT05326451
NCT03233646
Lead Sponsor
Luye Pharma Group Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions